论文部分内容阅读
目的:探讨尿微量蛋白分析对原发性高血压早期肾损害的临床预测价值。方法:选取本院所收治的原发性高血压患者220例,全部进行尿微量白蛋白测定,比较阳性检查率情况。结果:经检查分析,尿MALB、尿β2-MG、血β2-MG单项指标阳性率均高于尿常规蛋白阳性率和BUN、Cr阳性率,并均具有显著性差异,P<0.05。结论:尿微量白蛋白—尿MALB、尿β2微球蛋白—尿β2-MG、血β2微球蛋白—血β2-MG在原发性高血压早期肾损害预测中具有重要意义。
Objective: To investigate the clinical value of urinary microalbuminuria in predicting early renal damage in patients with essential hypertension. Methods: We selected 220 cases of patients with essential hypertension admitted to our hospital, all of them were tested for urinary albumin, and the positive rate was compared. Results: The positive rates of urinary MALB, urine β2-MG and blood β2-MG were all higher than those of urinary routine protein and BUN, Cr positive rate, all of which had significant difference (P <0.05). CONCLUSION: Urine microalbuminuria, urinary MALB, urinary β2 microglobulin-urinary β2-MG and β2 microglobulin-β2-MG are important in the prediction of early renal damage in patients with essential hypertension.